GlassScriptPhysician profile
George A Zikos
NPI 1740430941
$72,249.83
in general payments reported to CMS, 2019-2025
17 companies · $708 in 2025
The $708 reported for 2025 was more than what 85% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $68K · 2020: $23.54 · 2021: $333 · 2022: $1,169 · 2023: $1,496 · 2024: $976 · 2025: $708.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,180.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $67,931.12 | 2019-2025 | Acuvue |
| Sun Pharmaceutical Industries INC. | $1,177.47 | 2019-2025 | Cequa, Xelpros |
| Oyster Point Pharma, INC. | $1,024.48 | 2022-2025 | Tyrvaya, Ryzumvi |
| Bausch & Lomb Americas INC. | $998.14 | 2022-2025 | Infuse, Miebo, Xiidra |
| Coopervision INC. | $357.76 | 2022-2025 | Myday Contact Lens, Onefit Contact Lens |
| Alcon Vision LLC | $198.50 | 2019-2025 | Precision 1, Tryptyr |
| Tarsus Pharmaceuticals, INC. | $151.77 | 2024-2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $100.48 | 2021 | |
| Harrow Eye, LLC | $83.33 | 2024 | |
| Sight Sciences, INC. | $42.31 | 2022-2023 | Tearcare System |
| Visioneering Technologies, INC. | $40.00 | 2019 | |
| Kala Pharmaceuticals, INC. | $38.85 | 2021 | |
| Mylan INC. | $27.70 | 2025 | Tyrvaya |
| Abbvie INC. | $27.52 | 2024 | |
| Allergan, INC. | $27.45 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $22.95 | 2023 | Oxervate |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Zikos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.